Industry & Business
Siggy raises $6 million for AI that checks on therapy patients daily
A New York startup founded by Nurx and Journey Clinical alumni wants a daily AI score to catch the symptom changes a quarterly doctor's visit misses.
Topic
Industry & Business
Funding, partnerships, expansion, and company profiles across the wellness industry.
Showing 1 - 12 of 16 Articles
Industry & Business
WHOOP's Ulta Beauty deal puts a disputed health feature on the shelf.
WHOOP is about to reach 47 million beauty shoppers through Ulta, but its most medical-sounding feature still isn't FDA approved.
Industry & Business
Ozlo's $22 million raise bets sleep earbuds can also treat tinnitus.
The Boston sleep-earbud maker just closed a Series B that folds in old convertible notes, and its boldest new claim, that the buds can help tinnitus, rests on one unpublished study.
Industry & Business
Corxel's oral GLP-1 pill lands $377 million and a route to Nasdaq.
A SPAC merger will take obesity drug developer Corxel public with $377 million to fund its oral GLP-1 pill CX11, but the drug still has years of trials ahead and two rivals already in front of it.
Industry & Business
Yazen raises 50 million euros to pair Ozempic with coaching, despite a regulator's doubts.
The Swedish weight-loss clinic's biggest funding round yet is a bet that doctor-led coaching, not just the drug, is worth paying for.
Industry & Business
Stride's £4.6m raise, and its unproven biological age score
The Olympic medallist's testing startup just landed seed funding for a US launch and a new biological age score, but rival at-home age tests still disagree by over a decade for the same person.
Industry & Business
Function Health joins Google Health, and the hype check still applies.
Google will pull Function Health's $365-a-year lab results into its Health app this fall, but more biomarkers does not automatically mean better health decisions.
Industry & Business
Outro raised $7 million to help people quit antidepressants. The trials haven't caught up.
The deprescribing startup's seed round leans on a slow-taper method its own cofounder invented, and the randomized trial proving it beats standard tapering still hasn't finished.
Industry & Business
Altro Health raised $7 million to put peptides in gyms. The FDA hasn't approved any of it.
An NFX-backed startup wants peptides, GLP-1s and hormone therapy to be as easy to buy as a gym membership, on the strength of a regulatory vote that was only ever a recommendation.
Industry & Business
Grindr bought a PrEP clinic for $250 million. Its own data history complicates the pitch.
Grindr is paying $250 million, plus up to $70 million more, for the telehealth company behind Freddie, weeks after settling a $35 million lawsuit over sharing users' HIV status with advertisers.
Industry & Business
Tiny Health raised $33 million for gut testing. The eczema study is thinner than it sounds.
A microbiome testing startup used by nearly 200,000 customers just raised $33 million, leaning hard on one small, company-run infant eczema trial to make its case.
Industry & Business
Rightway raised $155 million to fix pharmacy benefits. Here's what it means for your GLP-1 bill.
A pharmacy benefit start-up just raised $155 million promising to pass GLP-1 rebates straight through to employers, and the fine print decides whether workers ever see the savings.